Revenue: The sum of all revenue fields included for a company's operating activities.
Entrada Therapeutics, Inc. (TRDA) had Revenue of $210.78M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$210.78M |
$65.63M |
|
-- |
|
$210.78M |
|
$163.77M |
|
$47.01M |
|
$19.47M |
|
$66.48M |
|
$66.48M |
|
$65.63M |
|
$65.63M |
|
$65.63M |
|
$65.63M |
|
$47.01M |
|
$40.77M |
|
37.31M |
|
39.00M |
|
$1.76 |
|
$1.68 |
|
| Balance Sheet Financials | |
$440.04M |
|
$10.93M |
|
$86.28M |
|
$526.32M |
|
$39.48M |
|
-- |
|
$58.16M |
|
$97.64M |
|
$428.68M |
|
$428.68M |
|
$428.68M |
|
37.57M |
|
| Cash Flow Statement Financials | |
$-41.56M |
|
$-27.80M |
|
$102.96M |
|
$71.55M |
|
$105.16M |
|
$33.61M |
|
$17.91M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
22.30% |
|
22.30% |
|
19.34% |
|
31.54% |
|
31.13% |
|
$-44.72M |
|
-- |
|
-- |
|
-- |
|
0.40 |
|
-- |
|
57.28 |
|
6.37 |
|
15.31% |
|
15.31% |
|
12.47% |
|
15.31% |
|
$11.41 |
|
$-1.15 |
|
$-1.07 |
|